Clinical Trial Update: A Study to Identify and Characterize LAL-D Patients in High-risk Populations

View source ↗

Summary

A terminated clinical trial update from Alexion investigating identification and characterization of patients with lysosomal acid lipase deficiency in high-risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lysosomal Acid Lipase Deficiency

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Lysosomal Acid Lipase Deficiency | Status: TERMINATED